Data as of Aug 29
| +0.06 / +2.60%|
The 3 analysts offering 12-month price forecasts for InspireMD Inc have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +132.07% increase from the last price of 2.37.
The current consensus among 3 polled investment analysts is to Buy stock in InspireMD Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.